| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |